Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AFH Atlas Financial		$0.10	$0.20 ▼ $2.45	$928K	1.12	1.95 million shs	23,687 shs
OXBR Oxbridge Re	$1.04 +1.0%	$1.03	$0.87 ▼ $2.03	$6.11M	0.86	12,435 shs	2,845 shs
TIL Instil Bio	$10.64 +2.2%	$11.49	$6.07 ▼ $14.00	$69.16M	1.24	27,295 shs	9,899 shs

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AFH Atlas Financial	0.00%	0.00%	0.00%	0.00%	0.00%
OXBR Oxbridge Re	-2.39%	-0.97%	-6.42%	-0.97%	-15.70%
TIL Instil Bio	-2.74%	-6.87%	-14.95%	+7.63%	-21.79%

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AFH Atlas Financial	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OXBR Oxbridge Re	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TIL Instil Bio	2.978 of 5 stars	3.3	5.0	0.0	0.0	1.5	3.3	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AFH Atlas Financial	N/A	N/A	N/A	N/A
OXBR Oxbridge Re	N/A	N/A	N/A	N/A
TIL Instil Bio	2.67	Moderate Buy	$36.00	238.35% Upside

Current Analyst Ratings

Latest TIL, OXBR, and AFH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/12/2024	TIL Instil Bio	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
3/25/2024	TIL Instil Bio	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$18.00
1/22/2024	TIL Instil Bio	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$18.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AFH Atlas Financial	$221.77M	0.00	N/A	N/A	$0.48 per share	0.00
OXBR Oxbridge Re	$850K	7.18	N/A	N/A	$0.91 per share	1.14
TIL Instil Bio	N/A	N/A	N/A	N/A	$34.72 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AFH Atlas Financial	-$80.01M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
OXBR Oxbridge Re	-$9.91M	-$1.69	N/A	∞	N/A	N/A	-90.92%	-72.10%	5/10/2024 (Estimated)
TIL Instil Bio	-$156.09M	-$23.99	N/A	N/A	N/A	N/A	-58.49%	-41.58%	5/9/2024 (Estimated)

Latest TIL, OXBR, and AFH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/26/2024	Q4 2023	OXBR Oxbridge Re	N/A	-$0.46	-$0.46	-$0.46	N/A	($1.91) million
3/21/2024	Q4 2023	TIL Instil Bio	N/A	-$1.99	-$1.99	-$1.99	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AFH Atlas Financial	N/A	N/A	N/A	N/A	N/A
OXBR Oxbridge Re	N/A	N/A	N/A	N/A	N/A
TIL Instil Bio	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AFH Atlas Financial	N/A	N/A	N/A
OXBR Oxbridge Re	N/A	5.26	5.26
TIL Instil Bio	0.36	15.23	15.22

Ownership

Institutional Ownership

Company	Institutional Ownership
AFH Atlas Financial	13.58%
OXBR Oxbridge Re	5.64%
TIL Instil Bio	60.56%

Insider Ownership

Company	Insider Ownership
AFH Atlas Financial	15.10%
OXBR Oxbridge Re	17.67%
TIL Instil Bio	54.70%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AFH Atlas Financial	N/A	11.94 million	N/A	Optionable
OXBR Oxbridge Re	4	5.87 million	4.83 million	Not Optionable
TIL Instil Bio	49	6.50 million	2.95 million	Optionable

TIL, OXBR, and AFH Headlines

Source	Headline
	Instil Bio (TIL) Price Target Decreased by 23.15% to 28.22 msn.com - April 17 at 12:21 PM
	Jefferies cuts Instil Bio to hold, cites drug discontinuation msn.com - April 12 at 1:45 PM
	Learning from nature, investing in people and ownership culture can future-proof the insight function research-live.com - March 29 at 7:34 AM
	What Makes Instil Bio (TIL) a New Buy Stock zacks.com - March 27 at 1:01 PM
	Instil Bio Non-GAAP EPS of -$1.26 beats by $2.14 seekingalpha.com - March 22 at 10:31 AM
	Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update globenewswire.com - March 21 at 5:00 PM
	UK Treasury to overhaul crypto regulations to strengthen AML measures forbesindia.com - March 14 at 7:37 AM
	A Very Private School — Charles Spencer’s privileged but painful education ft.com - March 12 at 9:18 AM
	Jon Cruddas: ‘Labour has to rediscover its moral purpose’ theguardian.com - March 11 at 2:59 PM
	Junglee Poker launches Apne Type Ke Log campaign featuring Anil Kapoor financialexpress.com - February 24 at 7:23 PM
	Instil Bio Stock (NASDAQ:TIL) Dividends: History, Yield and Dates benzinga.com - February 24 at 12:50 AM
	TIL therapies: the impact on cancer research labiotech.eu - February 22 at 2:43 PM
	Behind the new kind of cell therapy that just won FDA approval biopharmadive.com - February 22 at 8:26 AM
	Alexei Navalny death latest: Putin brings new criminal case against critic’s brother as mother pleads for body sg.yahoo.com - February 21 at 3:33 PM
	Alexei Navalny death latest: X restores wife Yulia’s account as Putin brings new case against critic’s brother independent.co.uk - February 20 at 11:59 PM
	How RSS textbooks are reshaping Indian history and science under Modi msn.com - February 19 at 9:49 AM
	Instil Bio Inc. thestreet.com - February 16 at 4:33 AM
	Boeing in ‘last chance saloon’, Emirates boss says msn.com - February 5 at 1:41 AM
	Auto industry stakeholders react to Interim Budget 2024 financialexpress.com - February 5 at 1:41 AM
	Interim Budget 2024: On path to a brighter and more prosperous India economictimes.indiatimes.com - February 2 at 7:52 AM
	Prezident Markon’s New Singles Round-up (Okvsho, Ivan Llanes, EDKUB, Sonoras Mil, Nina Camillo, Arthur Melo and more) soundsandcolours.com - January 31 at 1:44 AM
	Amber Ray, Rapudo's Baby Africanah Lands Lucrative Products Ambassadorial Job at 8 Months tuko.co.ke - January 31 at 1:44 AM
	Instil Bio hits four-month high on rising volumes msn.com - January 17 at 6:38 PM
	Instil Bio Announces Strategic Update finance.yahoo.com - January 16 at 10:09 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Nike Stock and the 30% Rally That's Expected
March 22, 2024 9:45 AM
View Nike Stock and the 30% Rally That's Expected
Best Bear Market Funds: Top 3 Investment Options to Consider
March 27, 2024 10:58 AM
View Best Bear Market Funds: Top 3 Investment Options to Consider
3 Most Active Penny Stocks: Buy, Sell, or Hold
April 4, 2024 9:25 AM
View 3 Most Active Penny Stocks: Buy, Sell, or Hold
Is DraftKings A Good Bet Ahead of Q1 Earnings?
March 27, 2024 10:45 AM
View Is DraftKings A Good Bet Ahead of Q1 Earnings?
3M Spun Off Its Health Division, Is It Still A Buy?
April 4, 2024 7:47 AM
View 3M Spun Off Its Health Division, Is It Still A Buy?

All Headlines

Company Descriptions

Atlas Financial

NASDAQ:AFH

Atlas Financial Holdings, Inc. engages in underwriting commercial automobile insurance policies through its subsidiaries. The firm focuses on the light commercial automobile sector, which includes taxi cabs, nonemergency para-transit, limousine, livery, and business auto. Its products and services include taxi, car service, limousine, paratransit, airport transit, and business auto. The company was founded on December 31, 2010 and is headquartered in Schaumburg, IL.

Oxbridge Re

NASDAQ:OXBR

Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology. In addition, the company offers fractional aircraft ownership, jet card, aircraft brokerage, and charter service through its fleet of private aircraft. It distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.

Instil Bio

NASDAQ:TIL

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecule to recognize folate receptor alpha, a tumor-associated antigen that is expressed on various solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial